Pfizer (PFE), BioNTech Seek EU Nod For Omicron-Based COVID Jab
Pfizer (NYSE: PFE) and its partner, BioNTech (NASDAQ: BNTX) announced that they have completed the submission of a regulatory application to the European Medicines Agency (EMA), which seeks authorization for thei
Benzinga ·